130 related articles for article (PubMed ID: 9539096)
1. Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection.
Chen CG; Salvaris EJ; Romanella M; Aminian A; Katerelos M; Fisicaro N; d'Apice AJ; Pearse MJ
Transplantation; 1998 Mar; 65(6):832-7. PubMed ID: 9539096
[TBL] [Abstract][Full Text] [Related]
2. Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection.
Cowan PJ; Chen CG; Shinkel TA; Fisicaro N; Salvaris E; Aminian A; Romanella M; Pearse MJ; d'Apice AJ
Transplantation; 1998 Jun; 65(12):1599-604. PubMed ID: 9665076
[TBL] [Abstract][Full Text] [Related]
3. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
[TBL] [Abstract][Full Text] [Related]
4. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.
Shinkel TA; Chen CG; Salvaris E; Henion TR; Barlow H; Galili U; Pearse MJ; d'Apice AJ
Transplantation; 1997 Jul; 64(2):197-204. PubMed ID: 9256173
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.
Sharma A; Okabe J; Birch P; McClellan SB; Martin MJ; Platt JL; Logan JS
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7190-5. PubMed ID: 8692967
[TBL] [Abstract][Full Text] [Related]
6. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection.
Pearse MJ; Witort E; Mottram P; Han W; Murray-Segal L; Romanella M; Salvaris E; Shinkel TA; Goodman DJ; d'Apice AJ
Transplantation; 1998 Sep; 66(6):748-54. PubMed ID: 9771838
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses.
Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF
Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558
[TBL] [Abstract][Full Text] [Related]
8. Delayed rejection of porcine cartilage is averted by transgenic expression of alpha1,2-fucosyltransferase.
Costa C; Brokaw JL; Wang Y; Fodor WL
FASEB J; 2003 Jan; 17(1):109-11. PubMed ID: 12475900
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice.
Cohney S; McKenzie IF; Patton K; Prenzoska J; Ostenreid K; Fodor WL; Sandrin MS
Transplantation; 1997 Aug; 64(3):495-500. PubMed ID: 9275118
[TBL] [Abstract][Full Text] [Related]
10. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.
Osman N; McKenzie IF; Ostenried K; Ioannou YA; Desnick RJ; Sandrin MS
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14677-82. PubMed ID: 9405672
[TBL] [Abstract][Full Text] [Related]
11. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection.
Cowan PJ; Somerville CA; Shinkel TA; Katerelos M; Aminian A; Romanella M; Tange MJ; Pearse MJ; d'Apice AJ
Transplantation; 1998 Mar; 65(6):826-31. PubMed ID: 9539095
[TBL] [Abstract][Full Text] [Related]
12. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression.
Murray-Segal L; Gock H; Cowan PJ; d'Apice AJ
Xenotransplantation; 2008 Feb; 15(1):20-6. PubMed ID: 18333910
[TBL] [Abstract][Full Text] [Related]
13. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
[TBL] [Abstract][Full Text] [Related]
14. In Contrast to Anti-C5 Therapy, Cobra Venom Factor Does Not Prevent Rejection of Xenogeneic Cartilage in Mice.
Brokaw JL; Costa C
Transplant Proc; 2015 Oct; 47(8):2397-9. PubMed ID: 26518939
[TBL] [Abstract][Full Text] [Related]
15. Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.
McKenzie IF; Li YQ; Patton K; Sandrin MS
Transplantation; 2000 Oct; 70(8):1205-9. PubMed ID: 11063342
[TBL] [Abstract][Full Text] [Related]
16. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice.
McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS
Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice designed to express human alpha-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection.
Liu B; Cheng C; Wu Y; Wei J; Li G; Ma T
Sci China C Life Sci; 2008 Mar; 51(3):199-204. PubMed ID: 18246307
[TBL] [Abstract][Full Text] [Related]
18. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.
Xu H; Yin D; Naziruddin B; Chen L; Stark A; Wei Y; Lei Y; Shen J; Logan JS; Byrne GW; Chong AS
J Immunol; 2003 Feb; 170(3):1531-9. PubMed ID: 12538718
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
20. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice.
Gock H; Salvaris E; Murray-Segal L; Mottram P; Han W; Pearse MJ; Goodman DJ; Cowan PJ; d'Apice AJ
Xenotransplantation; 2000 Nov; 7(4):237-46. PubMed ID: 11081758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
